Marker Therapeutics Competitors and Similar CompaniesClear all
Sellas Life Sciences's competitors and similar companies include ImmunoCellular Therapeutics and Advaxis.
 Sellas Life Sciences SELLAS Life Sciences is a clinical biopharmaceutical company focused on the development of cancer immunotherapies. |  ImmunoCellular Therapeutics ImmunoCellular Therapeutics is a clinical-stage biotechnology company developing immune-based therapies for the treatment of various cancers. | ||
Founding Date | Founding Date 2006 | Founding Date 2006 | Founding Date 2002 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations New York, US HQ New York, US | Locations Calabasas, US HQ | Locations Princeton, US HQ |
Employees | Employees 538% decrease | Employees 357% decrease | Employees 3540% decrease |
Valuation ($) | Valuation ($) 79.1 m | Valuation ($) 15.9 m | Valuation ($) 2.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $13k (FY, 2023) |
Net income | Net income ($26.9m) (FY, 2025) | Net income ($14.3m) (FY, 2017) | Net income ($48.1m) (FY, 2023) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 32.5m | Total funding raised $ 50.5m |
For sources of this data, please see the company profile
View Company Profiles
ImmunoCellular Therapeutics
HQ
Calabasas, US
Employees
3
ImmunoCellular Therapeutics is a clinical-stage biotechnology company developing immune-based therapies for the treatment of various cancers.
View company
Advaxis
HQ
Princeton, US
Employees
35↓ 40% decrease
Advaxis is a biotechnology company developing the next generation of cancer immunotherapies.
View company